DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 6.63 0.33%
market minute promo

8.11 0.14 (1.76%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SPPI $8.11 1.76%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.99
Previous Close $7.97
Daily Range $7.96 - $8.12
52-Week Range $6.36 - $10.32
Market Cap $533.1M
P/E Ratio -6.49
Dividend (Yield) $0.00 (0.0%)
Volume 457,277
Average Daily Volume 900,070
Current FY EPS -$0.68





Spectrum Pharmaceuticals, Inc. (SPPI) Description

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options. Website:

News & Commentary Rss Feed

A Bad Day for Spectrum Pharmaceuticals' Good News

Spectrum gets a drug approved, and then the share price drops.

Spectrum Pharmaceuticals: A Long-Term Bet

Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval

Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog

Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog

H.C. Wainwright & Co. Sees Significant Upside Ahead For Spectrum Pharmaceuticals

Spectrum Pharmaceuticals: Key Drug Fusilev May Face Generic Competition Soon

Spectrum Pharmaceuticals Gains U.S. Approval of Beleodaq - Analyst Blog

Why Spectrum Pharmaceuticals (SPPI) Stock Is Higher This Morning

Monday’s Top Biotech Stories: Spectrum, Bristol-Myers Squibb, GSK, and Theravance

Spectrum, Bristol-Myers Squibb, GSK, and Theravance are the top biotech stocks to watch this morning.

This Week in Biotech: Allergan Three-Peats in a Bad Way While Agenus Impresses

An early FDA approval, an inhaled therapy being turned away by regulators for a third time, and three positive clinical updates are this week's top biotech stories.

See More SPPI News...

SPPI's Top Competitors

SPPI $8.11 (1.76%)
Current stock: SPPI
JNJ $103.73 (0.76%)
Current stock: JNJ
NVS $89.84 (0.12%)
Current stock: NVS
RHHBY $36.51 (-0.14%)
Current stock: RHHBY